Social Links

Follow on Facebook Follow on TwitterFollow EiR on PinterestFollow EiR on Instagram

Xpert Access

×

Login To Get Involved!


Forgot your username?


Forgot your password?

×

Join Us At EiR Now!

DNRS Roof Banner

 

Summary of probiotic activities of Bifidobacterium lactis HN019

 

 

 

J Clin Gastroenterol. 2006 Oct;40(9):776-83.

 

Summary of probiotic activities of Bifidobacterium lactis HN019.

 

Sanders ME.Dairy and Food Culture Technologies, 7119 S. Glencoe Ct, Centennial, CO 80122, USA. This email address is being protected from spambots. You need JavaScript enabled to view it.

 

The bacterium, Bifidobacterium lactis HN019, has been studied for a variety of traits important to its ability to function as a probiotic. Publications documenting identity, safety, antipathogenic effects, immune enhancement, and intestinal colonization are reviewed. Most studies documenting immune effects are short term in duration (< or =6 wk feeding periods), so longer term trials would be useful to determine to what extent effects are sustained. One year-long trial feeding both galacto-oligosaccharides and HN019 in children 1 to 3 years of age provided evidence for improved growth and reduction in infection incidence. HN019 is a well-characterized probiotic strain with documented probiotic effects of meaningful magnitude especially in the area of immune system modulation.

 

PMID: 17016131 [PubMed - indexed for MEDLINE]


Full Article Available Online

 


 

 

Related Articles:

 

Mold Testing & Sanitizer:

 

 

 

 

ADVERTISEMENT

 

  • No comments found

Leave your comments

Post comment as a guest

0 Character restriction
Your text should be more than 25 characters
Your comments are subjected to administrator's moderation.
terms and condition.

Adsense Responsive BottomBanner